Global Antibody Production Industry is Expecting Major Revenue Growth in Near Future
A number of factors such as the improved approval rate for therapeutic antibodies by regulatory authorities, patent expiry of blockbuster monoclonal antibodies, increasing adoption of targeted immunotherapy, and increased R&D expenditure of pharmaceutical and biotechnology companies are key drivers for the growth of the antibody production market.This report studies the antibody production market...
Antibody Production Market worth 13.28 Billion USD by 2021
This report studies the Antibody Production Market for the forecast period of 2016 to 2021. This market is expected to reach USD 13.28 Billion by 2021 from USD 7.45 Billion in 2016, at a CAGR of 12.3%.
A number of factors such as the improved approval rate for therapeutic antibodies by regulatory authorities, patent expiry of blockbuster monoclonal antibodies, increasing adoption of targeted immunotherapy,...
Increasing Adoption of Targeted Immunotherapy Boosts the Technological Innovations in Antibody Production Market
The antibody production market comprises products that are required during the different stages of bioprocessing of antibodies, such as upstream processing, downstream processing, and filtration. The global antibody production market is projected to reach USD 13.28 Billion by 2021 from USD 7.45 Billion in 2016, at a CAGR of 12.3% during the forecast period of 2016 to 2021.
The improved approval rate...